Most online discussions of GHK-Cu serum formulation collapse into vague advice about "a few drops" or "follow the instructions." Neither is useful for investigators who want reproducible, concentration-controlled research batches. The peptide is not cheap, and a formulation error — wrong pH, incompatible carrier, thermal excursion — wastes both material and time. This guide takes a different approach: real numbers from the published literature, mapped directly to the vial sizes that are actually ghk-cu in stock UAE right now from REVIVE LAB UAE. The result is a formulation math reference you can run at the bench without guessing.
GHK-Cu is a naturally occurring copper-chelating tripeptide with the sequence Gly-His-Lys, first isolated from human plasma albumin in the 1970s by Pickart. The copper(II) ion coordinates between the histidine imidazole ring and the lysine amine, forming a stable 3D complex that is the biologically active unit. Three mechanisms matter for research-context formulation work:
Understanding these pathways matters for formulation because they tell you where GHK-Cu needs to arrive — the epidermis and upper dermis — and therefore what penetration-enhancing carrier strategy serves the research goal.
REVIVE LAB UAE supplies GHK-Cu as a lyophilized powder in sealed vials (50mg and 100mg). The first step is to reconstitute into a concentrated aqueous stock, then dilute into the final serum base. Use sterile water for injection or bacteriostatic water (BAC water) for the reconstitution. Do not reconstitute directly into glycol or alcohol-heavy carriers — the copper complex requires an aqueous phase first.
| Vial Size | Reconstitution Volume | Stock Concentration | Visual Check |
|---|---|---|---|
| GHK-Cu 50mg | 5 mL sterile/BAC water | 10 mg/mL | Clear light blue-green solution |
| GHK-Cu 100mg | 10 mL sterile/BAC water | 10 mg/mL | Clear light blue-green solution |
The characteristic pale blue-green colour of the reconstituted solution is normal and expected — it indicates intact Cu²⁺ chelation. A colourless solution suggests the copper may have dissociated; a dark precipitate indicates pH or temperature excursion. Reconstitute slowly, injecting water down the side of the vial rather than directly onto the lyophilized cake, and swirl gently. Do not vortex or shake.
Published research on GHK-Cu topical applications has used concentrations ranging from 0.05% to 0.5% (w/v). The 0.1% (1 mg/mL) mark is the most commonly cited research benchmark in the Pickart literature and represents a practical mid-range for investigator batches. Higher concentrations (0.5%) are used in wound-healing model studies where penetration depth to the dermal layer is the goal.
| Target Serum Concentration | From 50mg Vial (5 mL stock @ 10 mg/mL) | Final Serum Volume | Stock Used | Carrier Volume |
|---|---|---|---|---|
| 0.05% (0.5 mg/mL) | 50mg vial | 100 mL | 5 mL | 95 mL |
| 0.1% (1 mg/mL) | 50mg vial | 50 mL | 5 mL | 45 mL |
| 0.2% (2 mg/mL) | 50mg vial | 25 mL | 5 mL | 20 mL |
| 0.5% (5 mg/mL) | 50mg vial | 10 mL | 5 mL | 5 mL |
| Target Serum Concentration | From 100mg Vial (10 mL stock @ 10 mg/mL) | Final Serum Volume | Stock Used | Carrier Volume |
|---|---|---|---|---|
| 0.05% (0.5 mg/mL) | 100mg vial | 200 mL | 10 mL | 190 mL |
| 0.1% (1 mg/mL) | 100mg vial | 100 mL | 10 mL | 90 mL |
| 0.2% (2 mg/mL) | 100mg vial | 50 mL | 10 mL | 40 mL |
| 0.5% (5 mg/mL) | 100mg vial | 20 mL | 10 mL | 10 mL |
For investigators running comparative arms — e.g., 0.1% vs. 0.5% — the 100mg vial provides sufficient material to prepare both concentrations without opening a second vial. This is one reason research groups prefer the larger format when mapping dose-response relationships across tissue models.
The Cu²⁺ ion in GHK-Cu is coordination-bonded at neutral-to-slightly-acidic pH. Move outside the stability window and the complex degrades: the copper dissociates, the tripeptide chain loses its 3D geometry, and the biological activity characterised by Pickart & Margolina (2018) is no longer present in your formulation. The practical rule for research-context GHK-Cu serums:
GHK-Cu is water-soluble. The simplest research-context base is buffered aqueous — sodium phosphate or citrate buffer adjusted to pH 6.0 ± 0.2. For investigators interested in transdermal penetration enhancement, propylene glycol (PG) at 5–15% co-solvent concentration is compatible with the copper complex at the correct pH; higher PG concentrations (>30%) reduce aqueous activity and may affect chelation stability. Glycerine at 2–5% is commonly used as a humectant co-vehicle without affecting GHK-Cu stability at the concentrations relevant to topical serum research.
Carrier selection has a direct bearing on the penetration depth that Pickart (2008) documented in wound-healing models. Research-grade glycol-water co-solvent systems at pH 6.0 produced the dermal collagen responses that the wound-healing literature attributes to GHK-Cu; purely aqueous serums at the same concentration produced weaker signal, suggesting the carrier is not a passive vehicle in these experiments.
| State | Storage Condition | Estimated Stability | Key Risk Factor |
|---|---|---|---|
| Lyophilized (sealed REVIVE LAB UAE vial) | 2–8°C, dark, dry | 24+ months (per lot-COA) | Moisture ingress if seal compromised |
| Lyophilized (sealed vial) | Room temp, dark, <30°C | 7–14 days excursion | Humidity in UAE summer (>70% RH) |
| Reconstituted stock (10 mg/mL, BAC water) | 2–8°C, sealed vial, dark | 14 days | Microbial growth, pH drift |
| Reconstituted stock (sterile water) | 2–8°C | 7 days | No preservative protection |
| Finished serum (aqueous base, pH 6.0) | 2–8°C, opaque bottle | 7–14 days | Carrier oxidation, UV degradation |
| Finished serum (any) | Room temp, light exposure | <24 hours | Copper catalyses oxidation rapidly |
The stability data above reflects the research-use context. The single most common formulation failure is leaving a finished GHK-Cu serum at room temperature in a clear container — the copper ion is a powerful catalyst and UV/visible light accelerates oxidative breakdown. Store all research batches in amber or opaque containers at 2–8°C and label with the preparation date and expiry window.
The Campbell et al. 2012 paper in BMC Genomics is frequently cited but rarely read carefully. The investigators used microarray analysis to profile GHK's effect on gene expression across multiple human cell lines and found a surprisingly broad regulatory signature — approximately 4,000 genes showed statistically significant expression changes, spanning categories including:
For investigators building a topical serum research protocol, this gene-regulatory breadth is relevant to study design: it suggests GHK-Cu's effects are not limited to the collagen/ECM axis, and that transcriptomic readouts may provide more sensitive endpoint detection than collagen protein quantification alone.
Pickart's 2008 review in Advances in Wound Care remains the foundational synthesis document for GHK-Cu wound-healing research. Key findings relevant to formulation work:
One operational note from the Pickart 2008 methodology that directly affects formulation decisions: the wound-healing effects in the strongest models used GHK-Cu in a buffered aqueous gel base at pH 5.8–6.2 applied to the wound site. Formulations that drifted outside this pH range in the investigational product showed attenuated responses — reinforcing the pH constraint discussed in the carrier-selection section above.
The formulation math is only useful if the starting material is research-grade. GHK-Cu quality varies considerably between suppliers: molecular weight confirmation, purity by HPLC, and copper content verification are all required to know that what is in the vial matches the literature-referenced compound. REVIVE LAB UAE supplies GHK-Cu with HPLC purity verification (≥99%), lot-specific certificate of analysis (COA), and copper-chelation confirmed — the same quality parameters the Pickart and Campbell research groups implicitly assumed in their source material.
Both the 50mg and 100mg vials are available now — buy GHK-Cu UAE with cold-chain insulated dispatch, same-day delivery across Dubai, and next-day delivery to all six remaining emirates. Cash on delivery Dubai is supported, and REVIVE LAB UAE also accepts USDT (TRC20) crypto payment at a 5% pre-pay discount for investigators who prefer crypto pay Dubai settlement.
| Emirate / City | Delivery Window | Cash on Delivery | Cold-Chain Packaging |
|---|---|---|---|
| Dubai (Marina, JBR, Business Bay, JVC, DIFC, Downtown, Palm, Jumeirah) | Same-day, 4–8 hours | Yes | Yes |
| Abu Dhabi (Corniche, Yas, Saadiyat, Reem) | Next-day, 18–24 hours | Yes | Yes |
| Sharjah | Same-day / next-day, 8–18 hours | Yes | Yes |
| Ajman | Next-day, 18–24 hours | Yes | Yes |
| Ras Al Khaimah (RAK) | Next-day, 18–24 hours | Yes | Yes |
| Fujairah | Next-day, 24 hours | Yes | Yes |
| Umm Al Quwain (UAQ) | Next-day, 18–24 hours | Yes | Yes |
A researcher ordering GHK-Cu Dubai before 2pm typically has cold-pack vials in hand by early evening — enough time to prepare a reconstituted stock solution the same day without burning through the stability window. This is what ghk-cu Dubai 24h delivery looks like when the supplier is genuinely UAE-based and operating a real cold-chain courier network, not air-freighting from overseas on a 5-day lag.
REVIVE LAB UAE is a Dubai-based peptides UAE supplier — not a reseller relabelling offshore stock. Every GHK-Cu batch is HPLC-tested with the COA available before you order. Vials are dispatched from in-Dubai cold storage in insulated packaging that holds 2–8°C through the UAE summer transit. The 50mg and 100mg formats are both ghk-cu in stock UAE at all times, not on backorder or pre-order. REVIVE LAB UAE supplies HPLC-verified, lot-COA, cold-chain dispatched GHK-Cu across all 7 emirates — Dubai same-day, everywhere else inside 24 hours. For the broader research stack — Retatrutide (the GIP/GLP-1/glucagon triagonist), Tesamorelin (the GHRH analog), GHK-Cu, BPC-157, TB-500 — see the full REVIVE LAB UAE peptides catalogue. The point is straightforward: research-grade formulation math only holds if the source vial is research-grade from the start.
REVIVE LAB UAE stocks GHK-Cu in 50mg and 100mg vials, both HPLC-verified with lot-COA included. For a small 50mL research-context serum batch at 0.1% (1 mg/mL), a single 50mg vial is the exact quantity needed — no leftover reconstituted stock, no stability-clock waste. Investigators running larger 100mL batches, or testing two concentration arms in parallel, benefit from the 100mg vial. Both sizes are ghk-cu in stock UAE and dispatched same-day from Dubai with cold-chain insulated packaging.
Yes. REVIVE LAB UAE offers ghk-cu same day Dubai dispatch for orders placed before the daily cut-off, covering all Dubai zones including Marina, JBR, Business Bay, JVC, DIFC, Downtown, Palm Jumeirah, and Jumeirah. GHK-Cu Dubai 24h delivery extends across all six remaining emirates. All shipments include the HPLC certificate, cold-chain insulated outer packaging, and optional cash on delivery Dubai. Investigators can also pay via USDT (TRC20) crypto at a 5% pre-pay discount.
Reconstitute the lyophilized GHK-Cu powder in sterile water or bacteriostatic water to create a concentrated aqueous stock (e.g., 50mg in 5mL = 10 mg/mL). Then dilute into your pH-adjusted carrier base (target pH 5.5–6.5) to reach the desired final concentration. For 50mL at 0.1%: add 5mL of 10 mg/mL stock to 45mL of buffered carrier. Reconstituted stock holds 14 days at 2–8°C with BAC water (7 days with sterile water). Store the finished serum in an amber, opaque container at 2–8°C and use within 7–14 days. REVIVE LAB UAE GHK-Cu vials come lyophilized with lot-COA confirmation for research-grade starting material.